Company / Revenue
Arcutis Biotherapeutics, Inc. Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$376.1M
FY2025
5-year range
$3.7M / $376.1M
FY2022-FY2025
Trend
+91.3%
vs FY2024
Sector context
#74 of 155
Health Care
What the data says
At $376M, Arcutis Biotherapeutics, Inc.'s revenue ranks #74 of 155 in the Health Care sector. Revenue has increased for 3 consecutive years, from $4M in FY2022 to $376M in FY2025.
Based on SEC 10-K filings.
$376M in FY2025 with a 3-year CAGR of +367.3%.
Improved from $60M to $376M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +367.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 155 in Health CareTop 48% of 155This company $376.1M Sector average $4.5B
▼
-91.6% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s revenue has grown for 3 consecutive years.
- 3-year CAGR of +367.3%, indicating consistent growth.
- In FY2025, revenue increased 91.3% year-over-year.
- Ranks #74 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $376.1M | +91.3% |
| FY2024 | $196.5M | +229.7% |
| FY2023 | $59.6M | +1517.1% |
| FY2022 | $3.7M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026